APA (7th ed.) Citation

Liu, W., Yao, F., Wang, J., Shao, N., Cao, X., Dong, Z., . . . Sun, X. (2025). Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation. MDPI AG.

Chicago Style (17th ed.) Citation

Liu, Wenxiu, Fan Yao, Jinghan Wang, Nan Shao, Xinxin Cao, Zhengqi Dong, Bin Zhang, and Xiaobo Sun. Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation. MDPI AG, 2025.

MLA (9th ed.) Citation

Liu, Wenxiu, et al. Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation. MDPI AG, 2025.